A Report on Non-Ionizing Radiation

GBM: Microwave News Article Archive (2004 - )

October 26, 2018

Location, Location, LocationAggressive Brain Tumors Tell a Story

A U.K. epidemiologist has confirmed that glioblastoma (GBM), the most aggressive type of brain tumor, is on the rise in England. In a new paper, Frank de Vocht of the University of Bristol reports that he sees a significant and consistent increase in GBM in the frontal and temporal lobes of the brain over the last 20-30 years.

Alasdair Philips, an independent researcher based in Scotland, and three colleagues first documented the increase last March. It was not due to improved diagnosis, they said, but they could not pinpoint which “environmental or lifestyle factor” was responsible. There was one obvious possibility: cell phones.

October 18, 2018

“Analyses of Temporal and Spatial Patterns of GBM and other Brain Cancers Subtypes in Relation to Mobile Phones Using Synthetic Counterfactuals,” Environmental Research, posted October 17, 2018.

Frank de Vocht confirms that GBM is rising in the U.K. but argues that it’s “unlikely” that RF from cell phones is responsible.

March 25, 2018

Aggressive Brain Tumors on the Rise in England

The incidence of glioblastoma multiforme (GBM), the deadliest type of brain tumor, more than doubled in England between 1995 and 2015, according to a new analysis of national statistics. During that time, the number of cases of GBM rose from 983 to 2,531.

“We found a sustained and highly significant increase in GBM throughout the 21 years and across all ages,” said Alasdair Philips, the lead author of the study, which has just been released online by the peer-reviewed, open access, Journal of Environmental and Public Health.

“The incidence rate of GBM, the most aggressive and quickly fatal brain tumor, is rising dramatically in England while the rates for lower grade tumors have decreased, masking this dramatic trend in the overall data,” Philips told Microwave News from his home in Beeswing in southern Scotland, not far from the English border.

December 18, 2017

“Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients with Glioblastoma: A Randomized Clinical Trial,” JAMA, December 19, 2017.

Supplementing chemotherapy with 200 kHz E-fields increased progression-free survival (by 2.7 months to 6.7 months) and overall survival (by 4.9 months to 20.9 months) in patients with newly diagnosed glioblastoma. Both are statistically significant improvements.

August 30, 2017

NTP Cancer StudyNow Due Early 2018

The National Toxicology Program (NTP) will release the “complete results” of its $25 million project on cell phone cancer risks early next year, according to a statement posted on its Web site yesterday.

“The complete results from all the rats and mice studies will be available for peer review and public comment by early 2018,” the NTP states. The animals were exposed to GSM or CDMA radiation for two years before they were sacrificed...

January 31, 2017

Changing Mix of Brain Tumors in U.K.

The incidence of glioblastoma multiforme (GBM), the most virulent and deadly type of brain cancer, is going up in the U.K., while the incidence there of other types of malignant brain tumors are declining, according to some newly published raw data.

Take a look at the two plots below and the trends are immediately apparent.

The incidence rates are not corrected for age, or...

November 28, 2016

“Brain Cancer Patients Survive Longer By Sending Electric Field Through Their Heads,” IEEE Spectrum, November 22, 2016.

Novocure’s 200 kHz signals kept 43% of GBM patients alive compared to 30% on the standard treatment.

May 31, 2016

News Media Nix NTP Cancer Study“Don’t Believe the Hype”

Senior managers at the National Toxicology Program (NTP) released the preliminary results of their cell phone radiation study late last week. They were so concerned about the elevated rates of two types of cancer among exposed rats that they felt an immediate public alert was warranted. They considered it unwise to wait for the results to wend their way into a journal sometime next year. Not surprisingly, the NTP report generated worldwide media attention.

There were some startling reactions. Both the American Cancer Society (ACS) and Consumer Reports immediately shelved their long-held, wait-and-see positions. In a statement issued soon after the NTP’s press conference, Otis Brawley, ACS’ chief medical officer, called the NTP report “good science.” Consumer Reports said that the new study was “groundbreaking” and encouraged people to take simple precautions to limit their exposures.

However, much of the mainstream media saw it very differently. The Washington Post ran its story under the headline, “Do Cell Phones Cause Cancer? Don’t Believe the Hype.”

October 6, 2014

“Connection Between Cell Phone Use, p53 Gene Expression in Different Zones of Glioblastoma Multiforme and Survival Prognoses,” Rare Tumors, posted online August 8, 2014.

“Results from the present study on the use of mobile phones for ≥3 hours a day show a consistent pattern of increased risk for the mutant type of p53 gene expression in the peripheral zone of the glioblastoma, and that this increase was significantly correlated with shorter overall survival time. The risk was not higher for ipsilateral exposure.” From a German-Iranian team. Open access.